Available IPD datapackage for study 'A Phase 2 Efficacy And Safety Study Of SU011248 Administered In A Continuous Daily Regimen In Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma'
收藏DataCite Commons2025-11-07 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00006801.1
下载链接
链接失效反馈官方服务：
资源简介：
To evaluate the anti-tumor activity of SU011248 (sunitinib) in cytokine-refractory metastatic
renal cell carcinoma (RCC) when administered in a continuous treatment regimen
提供机构：
Vivli
创建时间：
2025-11-07
